Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 USD | +5.39% | +6.44% | -83.07% |
23/04 | Transcript : CNS Pharmaceuticals, Inc. - Special Call | |
01/04 | CNS Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar CNS Pharmaceuticals, Inc.
Upcoming events on CNS Pharmaceuticals, Inc.
Past events on CNS Pharmaceuticals, Inc.
09/04/2024 10:30 pm | LD Micro Invitational Conference |
05/04/2024 01:55 am | MedInvest Biotech & Pharma Investor Conference |
15/11/2023 06:30 pm | Q3 2023 Earnings Release |
15/11/2023 | Society of NeuroOncology Meeting |
25/10/2023 01:30 am | Ask The CEO Virtual Investor Conference |
15/09/2023 12:30 am | Annual General Meeting |
13/09/2023 08:00 pm | H.C. Wainwright Global Investment Conference |
14/08/2023 05:05 pm | Q2 2023 Earnings Release |
11/08/2023 06:00 am | SNO/ASCO CNS Cancer Conference - Abstract Code: TIPS-20 |
03/08/2023 09:05 pm | Benzinga Virtual Biotech Conference |
11/07/2023 09:30 pm | Virtual Investor Summer Spotlight Conference |
22/06/2023 12:00 am | Maxim Group Virtual Healthcare Conference |
15/05/2023 06:05 pm | Q1 2023 Earnings Release |
03/05/2023 09:30 pm | Virtual Investor Spotlight Conference |
05/04/2023 12:30 am | Investor Meeting - Key Opinion Leader |
03/04/2023 05:35 pm | Q4 2022 Earnings Release |
18/01/2023 08:30 pm | Virtual Investor Conference |
06/12/2022 09:30 pm | Ask the CEO Virtual Investor Conference |
15/11/2022 02:35 am | Q3 2022 Earnings Release |
28/09/2022 10:30 pm | Oncology Spotlight Featuring CNS Pharmaceuticals Virtual Investor Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -3,83 -1,40 -173.78% | -9,45 -8,51 -11.06% | -14,0 -15,7 10.51% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,88 -1,50 -158.48% | -9,46 -8,51 -11.1% | -14,0 -15,7 10.5% |
Net income Million USD | Released Forecast Spread | -3,88 -1,50 -158.48% | -9,46 -8,51 -11.1% | -14,0 -15,7 10.5% |
EPS USD | Released Forecast Spread | -8,40 -3,30 -154.55% | -17,1 -15,1 -13.43% | -15,9 -17,9 10.92% |
Announcement Date | 12/03/20 | 12/02/21 | 03/03/22 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
EBIT Million USD | Released Forecast Spread | -2,79 -4,44 37.11% | -2,78 -4,24 34.39% | -3,56 -3,15 -13.19% | -3,42 -3,85 11.29% | -4,03 -5,38 25.14% | -4,53 -5,89 23.02% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,80 -4,44 37.07% | -2,78 -4,24 34.33% | -3,57 -3,15 -13.24% | -3,42 -3,85 11.27% | -4,02 -5,38 25.21% | -4,52 -5,89 23.21% |
Net income Million USD | Released Forecast Spread | -2,80 -4,44 37.07% | -2,78 -4,24 34.33% | -3,57 -3,15 -13.24% | -3,42 -3,85 11.27% | -4,02 -5,38 25.21% | -4,52 -5,89 23.21% |
EPS USD | Released Forecast Spread | -3,00 -4,80 37.5% | -2,10 -3,30 36.36% | -2,70 -2,40 -12.5% | -2,70 -3,00 10% | -1,04 -2,82 63.12% | -1,08 -1,73 37.57% |
Announcement Date | 03/03/22 | 13/05/22 | 12/08/22 | 10/11/22 | 14/08/23 | 14/11/23 |
Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for CNS Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CNSP Stock
- Calendar CNS Pharmaceuticals, Inc.